Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion type Assertion NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_head.
- NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion description "[ The results of the study suggest that patients with COMT(L/L) genotype and possibly MAOB genotype A may benefit from more efficient and safer levodopa therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_provenance.
- NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion evidence source_evidence_literature NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_provenance.
- NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion SIO_000772 15355491 NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_provenance.
- NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion wasDerivedFrom gad-20150221 NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_provenance.
- NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_assertion wasGeneratedBy ECO_0000203 NP87772.RAbm4yDvL7h2QF8H2JZawc-bLMw72Le9WS4ncs1mfP14c130_provenance.